Book a meeting
DO-BO

How Can Innovation Planning Transform Market Access Success, Dr. Kasia Hein-Peters?

Tune in to the latest episode of MAP, the Market Access Podcast, where Dr. Stefan Walzer sits down with Amazon bestselling author Dr. Kasia Hein-Peters to explore the power of structured innovation planning.

Get a deeper understanding of how healthcare companies better can balance short-term commercialization with long-term innovation, as well as what roles of AI, digital twins and scenario-based planning play in shaping market access. 

Hear the expert insights on commercialization, reimbursement, and future-proofing market access strategies. From Horizon 1 (current business) to Horizon 3 (future disruptions), this episode unpacks the key strategies to ensure market access success in an evolving healthcare landscape.

Get the book: Innovation Planner 2025 by Dr Kasia Hein-Peters

Related

What Will It Take to Keep Biotech Growing in Europe, Rainer Westermann?

By

Stefan Walzer

In this episode of MAP – the Market Access Podcast, Dr. Stefan Walzer sits down with Rainer Westermann, Chairman of the Life Sciences Acceleration Alliance (LSAA), to ask whether Europe can remain a globally competitive home for life sciences innovation — and what has to change for new therapies to reach patients. Bringing an investor’s […]

How Do You Build a High-Performing Team in Pharma, Dr. Maurice Kléber?

By

Stefan Walzer

In this episode of MAP – the Market Access Podcast, Dr. Stefan Walzer sits down with Dr. Maurice Kléber to explore what building a winning team really takes — drawing on 18 years of leadership and a shared love of ice hockey. They discuss why trust and psychological safety are the foundation of any high-performing […]

Where Does AI Really Add Value in Market Access, Dr. Seye Abogunrin?

By

Stefan Walzer

Everyone wants AI to click the button for them — the real question is whether you still need to click it at all. In this episode of MAP – the Market Access Podcast, Dr. Stefan Walzer sits down with Dr. Seye Abogunrin, a health economist at Roche, Switzerland, to move AI in market access from […]